Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Traditional Chinese medicine state-based formula refers to a therapeutic intervention developed by Dongfang Hospital of Beijing University of Chinese Medicine, specifically for the treatment of multiple pulmonary nodules. This approach is rooted in 'state theory' (Zhuangtai theory), which posits that diseases arise from an imbalance in the body's internal environment or 'state.' The formula is designed to modulate this state to inhibit the development of nodules and promote their resolution. It is currently being evaluated in a randomized controlled trial (ChiCTR2300078250) that assesses efficacy through imaging, TCM syndrome scores, serum biomarkers, and psychological evaluations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on traditional Chinese medicine state-based formula.